Cardio Diagnostics Holdings(CDIO)
$1.92+0.06 (+3.23%)
CDIO
Cardio Diagnostics Holdings financials statements
$1.92
At close:+0.06 (+3.23%)
Cardio Diagnostics Holdings (CDIO) Ratios
292 Followers
Cardio Diagnostics Holdings Ratios
CDIO's free cash flow for Q3 2026 was $-1.52M. For the 2026 fiscal year, CDIO's free cash flow was decreased by $-4.00 and operating cash flow was $-1.52M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 9.79 | 13.92 | 3.29 | 3.02 | 23.71 |
| Quick Ratio | 9.79 | 13.92 | 3.29 | 3.02 | 23.71 |
| Cash Ratio | 8.45 | 12.39 | 1.53 | 2.11 | 15.13 |
| Solvency Ratio | -7.69 | -7.67 | -5.49 | -2.38 | -17.84 |
| Operating Cash Flow Ratio | -9.47 | -7.90 | -6.74 | -2.61 | -17.27 |
| Short-Term Operating Cash Flow Coverage | -21.23 | -16.28 | -15.17 | -6.00 | 0.00 |
| Net Current Asset Value | $ 5.13M | $ 7.73M | $ 1.26M | $ 3.94M | $ 769.62K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.09 | 0.28 | 0.14 | 0.00 |
| Debt-to-Equity Ratio | 0.10 | 0.10 | 0.43 | 0.20 | 0.00 |
| Debt-to-Capital Ratio | 0.09 | 0.09 | 0.30 | 0.16 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.11 | 1.11 | 1.51 | 1.45 | 1.03 |
| Debt Service Coverage Ratio | -21.38 | -24.86 | -0.22 | -5.47 | 0.00 |
| Interest Coverage Ratio | -438.08 | -448.81 | -1.08 | 0.00 | 0.00 |
| Debt to Market Cap | 0.06 | 0.00 | 0.01 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.41 | 0.04 | 18.91 | 0.27 | 0.00 |
| Net Debt to EBITDA | 0.73 | 0.85 | 0.01 | 0.70 | 0.85 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -43732.65% | -23974.82% | -9620.98% | -490630.00% | -68862.15% |
| EBITDA Margin | -41047.14% | -23182.77% | -8966.90% | -488945.79% | -67086.35% |
| Operating Profit Margin | -43737.46% | -23977.86% | -42440.43% | -478784.32% | -68862.15% |
| Pretax Profit Margin | -43832.49% | -24028.24% | -49087.81% | -490630.00% | -68862.15% |
| Net Profit Margin | -43832.49% | -24028.24% | -49087.81% | -490630.00% | -68862.15% |
| Continuous Operations Profit Margin | -43832.49% | -24028.24% | -49087.81% | -490630.00% | -68862.15% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.22% | 100.21% | 115.66% | 102.47% | 100.00% |
| Return on Assets (ROA) | -83.67% | -78.98% | -187.72% | -74.58% | -56.30% |
| Return on Equity (ROE) | -93.19% | -87.71% | -283.18% | -108.35% | -58.09% |
| Return on Capital Employed (ROCE) | -90.54% | -83.80% | -200.00% | -105.74% | -58.09% |
| Return on Invested Capital (ROIC) | -84.55% | -79.47% | -171.66% | -88.31% | -58.09% |
| Return on Tangible Assets | -94.27% | -84.61% | -213.39% | -79.12% | -77.22% |
| Earnings Yield | -136.91% | -1.13% | -26.52% | -4.75% | -0.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.82 | 1.87 | 3.44 | 0.00 | 1.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Cash Conversion Cycle | 200.07 | 194.71 | 106.09 | 0.00 | 365.00 |
| Days of Sales Outstanding | 200.07 | 194.71 | 106.09 | 0.00 | 365.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 200.07 | 194.71 | 106.09 | 0.00 | 365.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.27 | -0.19 | -13.41 | -1.65 | -1.85 |
| Free Cash Flow Per Share | -3.38 | -0.20 | -15.29 | -1.65 | -2.20 |
| Dividend Paid and CapEx Coverage Ratio | -30.57 | -12.35 | -7.14 | -2545484.00 | -5.13 |
| Capital Expenditure Coverage Ratio | -30.57 | -12.35 | -7.14 | -2545484.00 | -5.13 |
| Operating Cash Flow Coverage Ratio | -8.23 | -5.15 | -4.50 | -6.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -386.30 | -143.11 | -332.39 | -5358.91 | -649.60 |
| Free Cash Flow Yield | -124.60% | -0.73% | -20.47% | -5.18% | -0.75% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.73 | -2.96 | -3.77 | -21.07 | -150.59 |
| Price-to-Sales (P/S) Ratio | 320.16 | 21204.54 | 1850.92 | 103366.74 | 103701.16 |
| Price-to-Book (P/B) Ratio | 0.68 | 77.41 | 10.68 | 22.83 | 87.48 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.80 | -137.07 | -4.88 | -19.29 | -133.61 |
| Price-to-Operating Cash Flow Ratio | -0.83 | -148.17 | -5.57 | -19.29 | -159.64 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.06 | 0.07 | -0.01 | -0.05 |
| Enterprise Value Multiple | -0.05 | -90.62 | -20.63 | -20.44 | -153.73 |
| Enterprise Value | 331.33K | 732.97M | 31.56M | 94.93M | 92.92M |
| EV to EBITDA | -0.05 | -90.62 | -20.63 | -20.44 | -153.73 |
| EV to Sales | 22.35 | 21007.99 | 1849.60 | 99926.22 | 103132.05 |
| EV to Free Cash Flow | -0.06 | -135.80 | -4.88 | -18.65 | -132.87 |
| EV to Operating Cash Flow | -0.06 | -146.80 | -5.56 | -18.65 | -158.76 |
| Tangible Book Value Per Share | 3.48 | 0.33 | 5.73 | 1.28 | 2.43 |
| Shareholders’ Equity Per Share | 3.98 | 0.36 | 7.00 | 1.39 | 3.37 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.00 | 0.04 | 0.00 | 0.00 |
| Net Income Per Share | -3.71 | -0.31 | -19.81 | -1.51 | -1.96 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 5.10 | 1.00 | 1.00 |
| Research & Development to Revenue | 43.25 | 6.53 | 8.51 | 42.58 | 34.93 |
| SG&A to Revenue | 390.72 | 233.68 | 406.48 | 4631.85 | 522.27 |
| Stock-Based Compensation to Revenue | 7.44 | 74.27 | 74.96 | 0.00 | 66.59 |
| Income Quality | 0.88 | 0.60 | 0.68 | 1.09 | 0.94 |
Currency in USD
